Y10S 424/832
Involving bacterial toxin that has modified amino acid sequence
Official title: involving bacterial toxin that has modified amino acid sequence
Y10S424/832 (Involving bacterial toxin that has modified amino acid sequence) appears on 71 US grants and 24 published applications in this corpus.
Search patents in Y10S- Granted patents
- 71
- Published applications
- 24
- Assignees
- 55
- Inventors
- 96
- Latest grant
- 21 Oct 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 6 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 1 | 0 |
| 2002 | 4 | 4 |
| 2003 | 1 | 2 |
| 2004 | 3 | 3 |
| 2005 | 2 | 1 |
| 2006 | 1 | 3 |
| 2007 | 3 | 1 |
| 2008 | 0 | 3 |
| 2009 | 4 | 3 |
| 2010 | 1 | 0 |
| 2011 | 6 | 1 |
| 2012 | 1 | 3 |
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Diphtheria toxin variant21 Oct 2014US 8,865,866 B2Anjin Group, Inc.
- Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers24 Dec 2013US 8,613,929 B2To-Bbb Holding B.V.
- Clostridial toxin derivatives able to modify peripheral sensory afferent functions17 Apr 2012US 8,158,132 B2Syntaxin Limited
- Diphtheria toxin variant1 Nov 2011US 8,048,985 B2Anjin Group, Inc.
- Methods and compositions for targeting agents into and across the blood-barrier and other endothelial cell microvascular barriers27 Sep 2011US 8,026,209 B2BBB Holding B.V.
- Diphtheria Toxin Variant14 Jun 2012US 2012/0149650 A1Anjin Group, Inc.
- Clostridial toxin derivatives able to modify peripheral sensory afferent functions7 Jun 2012US 2012/0141511 A1Ipsen, Inc.
- Polypeptide carrier protein22 Mar 2012US 2012/0070456 A1
- Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers10 Nov 2011US 2011/0274749 A1BBB Holding B.V.
- Polypeptide carrier protein10 Sep 2009US 2009/0227770 A1Novartis AG
Most cited
By later US patents
- Clostridial toxin derivatives able to modify peripheral sensory afferent functions318US 5,989,545 AMicrobiological Research Authority · 1999
- Immunogenic conjugates154US 4,673,574 A1987
- Oligosaccharide conjugate vaccines99US 5,153,312 AAmerican Cyanamid Company · 1992
- Immunogenic conjugates93US 4,902,506 AUniversity of Rochester · 1990
- Bacillus thuringiensis delta-endotoxin81US 5,593,881 AMycogen Corporation · 1997